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Abstract
Single-walled carbon nanotubes (SWNT) are particularly attractive for biomedical applications,
because they exhibit a fluorescent signal in a spectral region where there is minimal interference
from biological media. Although SWNT have been used as highly-sensitive detectors for various
molecules, their use as in vivo biosensors requires the simultaneous optimization of various
parameters, including biocompatibility, molecular recognition, high fluorescence quantum
efficiency and signal transduction. Here we demonstrate that a polyethylene glycol ligated
copolymer stabilizes near infrared fluorescent SWNT sensors in solution, enabling intravenous
injection into mice and the selective detection of local nitric oxide (NO) concentration with a
detection limit of 1 μM. The half-life for liver retention is 4 hours, with sensors clearing the lungs
within 2 hours after injection, thus avoiding a dominant route of in vivo nanotoxicology. After
localization within the liver, it is possible to follow the transient inflammation using NO as a
marker and signalling molecule. To this end, we also report a spatial-spectral imaging algorithm to
deconvolute fluorescence intensity and spatial information from measurements. Finally, we show
that alginate encapsulated SWNT can function as an implantable inflammation sensor for in vivo
NO detection, with no intrinsic immune reactivity or other adverse response, for more than 400
days. These results open new avenues for the use of such nanosensors in vivo for biomedical
applications.
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Single-walled carbon nanotubes as optical sensors are photostable and fluoresce in the near-
infrared where blood and tissue absorption and autofluorescence is minimal1. SWNT have
demonstrated single-molecule sensitivity, and can be functionalized to selectively detect a
variety of molecules2, including alkylating chemotherapeutic drugs, hydrogen peroxide3,4
and NO5,6. SWNT have been functionalized for biocompatibility, demonstrating long
circulation times7–11, favorable biodistribution in several mammalian animal models12,13,
and highly favorably toxicological profiles for in vivo utility10,14–19. Proposed in vivo uses
of SWNT include image contrast agents for bioimaging and drug delivery agents7,9,
however their use as diagnostic sensors has not yet been demonstrated in vivo. Such use
requires a synthetic strategy that incorporates biocompatibility, molecular recognition, high
quantum efficiency and optical transduction of analyte binding.
In this work, we address these constraints by reporting the synthesis and operation of a
complex that allows for analyte detection from within complex tissues and organs in vivo.
The in vivo detection of nitric oxide (NO) is utilized as a model since it is a free-radical
involved in diverse biological processes, such as apoptosis, neurotransmission, blood
pressure control and innate immunity20 and has not been probed in intraperitoneal tissues.
Current technology allows for in vivo NO detection through an electrochemical probe
surgically implanted in a rat's brain21, but does not permit long term or non-invasive NO
detection. Of critical importance to NO function is its steady-state concentration in tissues,
with biologically relevant concentrations ranging over three orders-of-magnitude. On the
basis of literature estimates, Thomas et al.22 proposed the following concentration categories
for NO functions: (a) GMP-mediated signalling processes at 1–30 nM;(b) modulation of
kinase and transcription factor activity at 30–400 nM; and (c) pathological nitrosative and
oxidative stresses above 500 nM. Activated macrophages are the major source of
pathologically high levels of NO23, producing local steady-state concentrations approaching
1 μM24. NO rapidly reacts with superoxide anion (O2˙−) to form peroxynitrite (ONOO−), a
potent oxidant. Peroxynitrite further reacts with CO2 to form nitrosoperoxycarbonate
(ONOOCOO−), which decomposes into nitrogen dioxide (NO2˙) and carbonate radical
(CO3˙−), which are also very strong oxidants. Overproduction of these reactive species in
chronic inflammation can cause damage to all types of cellular biomolecules and thus
contribute to the mechanistic link between inflammation and diseases such as cancer24,25.
We tested single-walled carbon nanotubes in several contexts, including subcutaneously
implanted sensors for inflammation detection and circulating sensors that localize within the
liver for detection of reactive nitrogen species derived from NO. By specifically designing
the chemical interface between organism and sensor, we show for the first time that in vivo
detection using this type of platform is possible.
The chemical and optical constraints of in vivo sensing
Using the SWNT as a fluorescent sensor in vivo introduces additional complexities over
those of a passive delivery agent or imaging fluorophore. The SWNT must be functionalized
such that selective molecular recognition is enabled, and that recognition is transduced
optically by the SWNT. However, the selective coating must also allow for biocompatibility
and stability in vivo, a constraint that significantly limits the available interfaces that can be
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used. Fluorometric sensors based upon SWNT or other nanoparticles necessarily optimize
the extent and selectivity of modulation for a particular analyte over interfering
molecules4–6,26–29. However, operation in vivo adds the constraint that an adequate quantum
yield must be maintained to allow detection from within tissue while remaining operable
after conjugation with stabilizing components essential for in vivo biocompatibility.
To address these constraints, we find that a DNA oligonucleotide ds(AAAT)7 allows for
nitric oxide selectivity that is maintained after ligation to a 5 kDa MW poly ethylene glycol
(PEG) segment (Fig. 1a). SWNT were dispersed using both the PEG-ligated and un-ligated
DNA versions and tested for fluorescent modulation upon exposure to 30 μM nitric oxide
and a battery of common potential interfering molecules, showing a 25% and 17%
respectively greater reactivity to NO than any other analyte (Fig. 1b). Interestingly, addition
of PEG decreases the SWNT response to HNO, and overall selectivity to NO is substantially
higher than a diaminofluorescene standard, which measures only oxidation products of NO,
and not the analyte directly, with an NO detection limit of less than 1 μM (Supplemental
Fig. S1). The dynamic response and reversibility for both the PEG attached and
unfunctionalized sensors appear in Fig. 1c. The rapid initial quenching rate is invariant for
either construct, followed by a slower recovery due to solution degradation of the NO. The
reversibility and rapidity of the response mean that for the first time this probe can be
utilized to study NO signalling dynamics in vivo.
Spatial and Tissue Spectroscopic Imaging by Chemical Sensors
Unlike an invariant fluorescent or radiometric probe, an optical sensor must report both its
position within the tissue and its chemical environment via either intensity or wavelength
modulation. Hence, schemes that provide 2D static or dynamic images of fluorometric
probes in vivo, and necessarily utilize intensity information to reveal location, cannot be
used for chemical sensing. The development of liquid crystal tunable grading and filter
technology provides a technological solution. By continuously tuning the grating to select a
narrow wavelength space, an image stack I(x,y,λ)raw can be efficiently obtained via a rapid
scan containing two spatial coordinates and the wavelength axis. We utilized a liquid crystal
filter that afforded wavelength detection from 950 to 1050 nm, imposed upon a conventional
whole animal field of view in a dark-box imaging configuration. The 2Dλ image stack easily
encodes both spatial and chemical information, as demonstrated by the deconvolution of the
raw stack to background and sensor components, allowing comparative fluorescence
quenching (Fig. 1d). We find that the narrow fluorescent full width at half maximum of the
PEG SWNT sensor (100 nm) is easily deconvoluted from the sloping autofluorescence
background typically encountered in natural and synthetic media. Using a custom Matlab
algorithm (see Supplemental Information) applied to SWNT immobilized within tissue, we
rapidly reduce the raw image intensity stack I(x,y,λ)raw into SWNT fluorescence,
background and autofluorescent noise components:
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Here, k is a proportionality constant of calibration (assumed linear) containing the molar
extinction coefficient of the SWNT probe (4400 +/− 1000 M−1 cm−1)30. Note that this
scheme easily lends itself to the multiplexing of fluorescent sensors in the wavelength band,
or the analysis of the autofluorescence background or tissue absorption simultaneously with
the SWNT sensor probe. Unless otherwise noted, fluorescent images in this work are
I(x,y)SWNT spatial maps in which fluorescent intensity corresponds to relative NO
concentration via quenching once normalized31. To find the relative contribution of the
SWNT fluorescence, background and autofluorescence noise at each point, a least squares
minimization of a linear fit of the fluorescence spectrum was performed (see Supplemental
Information).
Stability to Tail Vein Injection
Ligation of PEG to the sensor interface is critical for successful circulation in vivo. For
example, we find that (AAAT)7-SWNT does not circulate, instead accumulating near the
injection site, as shown using near-infrared imaging in Fig. 2a. Figure 2a shows the
administration of (AAAT)7-SWNT to first the left and then the right tail vein of a mouse.
This procedure was done repeatedly with similar results; (AAAT)7-SWNT blocks the tail
vein, inhibiting solution injection and blood flow. The insert in the image shows a cross
section of the tail with the (AAAT)7-SWNT located within the veins, not the surrounding
tissue. Hence, the vein occlusion was attributable to instability of the (AAAT)7-SWNT and
not to erroneous injection. Further experiments show that tail vein blockage is caused by
aggregates of serum proteins adsorbed to (AAAT)7-SWNT. Gel electrophoresis in Fig. 2b
shows four samples ((AAAT)7-SWNT and PEG-(AAAT)7-SWNT samples incubated with
either fetal bovine serum (FBS) or buffer for 5 minutes before loading) and their migration
distances as measured by fluorescence emission versus position. The zero point is the edge
of the well with the fluorescence intensity measured at 1 mm distance intervals for all
samples. The electrophoretic mobility of (AAAT)7-SWNT is 11*109 to 14*109 m2 V−1
while its FBS containing counterpart's mobility is 2*109 to 4*109 m2 V−1; confirming
adsorption of FBS to (AAAT)7-SWNT. Both the PEG-(AAAT)7-SWNT solutions with and
without FBS had electrophoretic mobilities of 10*109 to 14*109 m2 V−1 with no perceptible
difference between the two, confirming that the PEG moiety on the PEG-(AAAT)7-SWNT
prevents FBS adsorption. Our hypothesis that tail vein occlusion was caused by protein
binding to (AAAT)7-SWNT was confirmed by visual inspection of the clearance of PEG-
(AAAT)7-SWNT following injection into the vein, as shown in Fig. 2c. We conclude that
addition of PEG moieties is necessary to produce stable preparations for in vivo circulation
of this type of sensor.
Circulation Time and Biodistribution
Having optimized intravenous administration of SWNT, we turned our attention to
biodistribution and biocompatibility of SWNT as it is injected and localized within tissue,
with results shown in Fig. 3. Figure 3a presents histology of liver tissue (tail, lung and
kidney tissues are shown in Supplemental Fig. S2) before and after injection of PEG-
(AAAT)7-SWNT, and shows no evidence of an inflammatory response. Animals were
injected with PEG-(AAAT)7-SWNT via the tail vein, then sacrificed at 5, 15, 30, 60 and 120
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min after the injection (n=3–5 mice per time point); 0 min time point represents control
animals that did not receive PEG-(AAAT)7-SWNT. Histological examination of
hematoxylin and eosin (H&E) stained tissues shows no detectable evidence of inflammation
in tail, lungs, liver or kidneys at any time. Figure 3b shows the presence (+) or absence (−)
of PEG-(AAAT)7-SWNT in tissue samples, as determined by Raman spectroscopy (n=3
mice per time point) (sample spectrum shown in Fig. 3c). Resonance Raman spectroscopy of
blood and urine samples shows the presence of SWNT in blood at all points, but no SWNT
in urine samples collected from the bladder at each time point, confirming that SWNT
remains in vivo for at least 2 hours. PEG-(AAAT)7-SWNT was also detected in liver and
kidneys for the entire 2 hour time interval, but cleared the tail injection site within 1 hour.
Clearance of SWNT from the lungs is particularly noteworthy. Due to the highly
vascularized nature of lung tissue and its position within the systemic circulation, the lungs
are highly susceptible to nanoparticle trapping32–34. Remarkably, visual inspection revealed
darkening of the lung tissue 5 minutes after injection, but tissue returns to pretreatment
coloration within 30 minutes. This observation was documented quantitatively by Raman
tissue spectroscopy, which confirmed that PEG-(AAAT)7-SWNT was detectable in the
lungs 5 minutes after injection but cleared within two hours. This evidence directly supports
the ability of PEG-(AAAT)7-SWNT to penetrate restrictive capillary networks without
causing occlusions.
We observed PEG-(AAAT)7-SWNT accumulation in multiple tissues, but noted the highest
concentration in the liver. Figure 3d,e summarizes qualitative and quantitative evidence of
PEG-(AAAT)7-SWNT accumulation in excised livers of mice sacrificed 5, 15, 30, 60 and
120 min after injection, as in the biodistribution study described above. Representative
images of the liver clearly show an increase in SWNT fluorescence up to 30 min, followed
by a small decrease. Quantitative analysis, performed with the 2Dλ approach described in
Fig. 1, shows that the average fluorescence for the livers increases up to 30 min, then
decreases slightly and stays constant up to 60 and 120 min. Samples that have been
quenched show a fluorescence distribution with larger standard deviations and lower peak
value compared to non-quenched samples, shown in Supplemental Fig. S3. The fluorescence
distribution of the data from Fig. 3e, shown in Fig. 3f, shows similar peak values and
standard deviations for all time points, implying an increase and then decrease in PEG-
(AAAT)7-SWNT concentration within the liver as opposed to SWNT quenching after the 30
min time point.
Accumulation of the PEG-(AAAT)7-SWNT in the liver can be modeled (see supplementary
information), regression of the data in Fig. 3e yields a SWNT concentration within the liver
of B(t) = B0(e−k1t − e−k2t), where B0 is −346.51, k1 is 0.1169 and k2 is 0.00288 and a half
life of approximately 4 hours (see detailed description in Supplementary Information). More
accurate liver half-life values require a more detailed model informed by longer time points,
the focus of future efforts. Also of interest are blood concentration studies to enable for
bloodstream half-life determination.
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Detection of Nitric Oxide in Inflamed Mouse Liver
Having established the detectability of PEG-(AAAT)7-SWNT in mouse livers, we assessed
the ability of the sensor to detect NO produced during inflammation in vivo. For this
purpose, we could have used any mouse model, but chose the SJL mouse due to its intense
inflammatory response resulting in massive overproduction of NO over a predictable time
course after induction by an injection of RcsX tumor cells, as previously described35.
Accordingly, mice were injected intraperitoneally with RcsX cells35 or saline (n=10,
repeated once with n=5). After 12 days, PEG-(AAAT)7-SWNT was injected into the tail
vein of anesthetized mice, and 30 minutes later a cut in the abdominal cavity exposed the
liver to allow in situ imaging (Fig. 4a). Immediately thereafter the animal was sacrificed, the
liver excised and the isolated organ imaged a second time. Comparison of in situ images
shows that livers of control animals clearly displayed fluorescence, whereas it was
undetectable in inflamed organs of RcsX treated mice. In contrast, images of excised livers
show that similar levels of SWNT fluorescence are present in both RcsX and control
animals. We conclude that absence of fluorescence in the in situ images was attributable to
NO generated during inflammation, since SWNT was clearly present in the organs as shown
by fluorescence in excised organs. The rapid recovery of PEG-(AAAT)7-SWNT
fluorescence after exposure to NO (Fig. 1c) is consistent with this interpretation.
Quantification of these data was performed (Fig. 4b) and showed a 55% difference between
pre- and post-sacrifice fluorescence in inflamed tissues compared to 3% difference in
controls. Fluorescence distribution data shows the similarity between tissue of control mice
without SWNT and the signal detected in the inflamed animals with injected SWNT (39 and
54 a.u. mm−2 compared to 153 a.u. mm−2 for non-inflamed mice with SWNT) while the
excised liver samples for both inflamed and non-inflamed mice have similar standard
deviations (48.14 and 43.41 a.u.) and peak values (148 and 158 a.u.). A limitation of this
study is the need to expose the liver for in situ imaging, which we propose to address by
further optimization of the SWNT to enable deeper tissue imaging or the use of a
laproscopic probe to allow imaging with an even smaller incision than currently used.
A Nitric Oxide Monitor for Epidermal Tissue Inflammation
We also investigated the potential of tissue-specific localization of (AAAT)7-SWNT using
an alginate-encapsulated sensor platform that can be implanted and perform on a multiple
day/months time scale as opposed to the shorter time scale utilized by the intravenously
injected PEG-(AAAT)7-SWNT. Figure 5a shows that the alginate-(AAAT)7-SWNT sensor
retains its NO specificity. Interestingly, the fluorescence signal was quenched less rapidly by
NO, reaching 93% quenching after 30 minutes of NO exposure (Fig. 5b). The signal
remained quenched for 24 hours, after which it returned to 25% after 41 hours. Several
possible mechanisms could be responsible for the delayed fluorescence recovery. It is
possible that NO adsorbed to alginate-(AAAT)7-SWNT is more stable than free NO,
increasing its half-life significantly and causing the NO to be concentrated in the alginate
hydrogel. It is also possible that a long-lived reactive derivative of NO is responsible for the
quenching of the alginate-(AAAT)7-SWNT system. This seems plausible if the NO enters
the alginate hydrogel and reacts with another negatively charged analyte trapped in the
Iverson et al. Page 6













alginate matrix. Another possibility is that NO forms an alginate intermediate that quenches
the SWNT.
Subcutaneous implantation and NO detection was performed with alginate encapsulated
(AAAT)7-SWNT, with results shown in Fig. 5. The first study (Fig. 5c), involved
subcutaneous placement of two alginate-(AAAT)7-SWNT gels on both the left and right
flanks of a mouse. We observed total signal quenching of gel 1 in the first image, taken
approximately 20 minutes after the gel was placed, while gel 2 retained its fluorescence. In a
subsequent image, after gel 2 was in the animal for approximately 20 minutes, gel 2 was
also quenched. By day 4 both gels regained their fluorescence. Few quantitative data are
available on in vivo levels of NO, which are thought to be very low (i.e., nM) in non-
inflamed tissues. However, during a wound healing study by Lee et al. it was shown that NO
levels in rat wound fluid increased steadily from 27 to 107 μM over a 14 day period, with
nitric oxide synthase activity peaking at 24 hours post injury36. Therefore the concentration
of NO in the wound bed can be high enough to quench the SWNT shortly after implantation.
In our study with alginate gels in mice we did not see the prolonged NO presence that Lee et
al. observed with polyvinyl alcohol sponges in rats, but we also did not see the recruitment
of macrophage cells, known NO producers, or foreign body response that has been
associated with polyvinyl alcohol sponges36,37. These observations support the
interpretation that the absence of signal observed on day 0 of our experiments resulted from
fluorescence quenching associated with a burst of NO due to gel implantation, not to tissue
interference with the fluorescence. This fast quenching and multiple day signal recovery
corresponds to the data shown in Fig. 5b. Tissue from the animal was collected post-
sacrifice on day 4 and stained with H&E (Fig. 5e). Negligible inflammation was present at
the site of implantation, also supporting our hypothesis relating to the fluorescence signal
recovery that was observed.
Figure 5d and 5f shows the results from an unprecedented long-term durability study of the
alginate-(AAAT)7-SWNT. Here, a single subcutaneous gel implantation into the right flank
was monitored and fluorescence imaged for 60 to 400 days, far longer than implantable
electrochemical sensors, the closest current technology, have been shown to monitor NO38.
In Fig. 5d the gel is shown prior to implantation and then in vivo for multiple points during a
300 day study. Prominent fluorescence can be seen throughout the 300 days of the study.
Gel morphology appears to change slightly over time due to animal movement, but the gel
remains intact and the signal is largely invariant, as seen in Fig. 5f. Quantification of
fluorescence intensity over the experimental time course is charted in Fig. 5f (signal
recovery after implantation shown in Supplemental Fig. S4). . The signal was retained over
the entire period, with variability of 14% in intensity. The small variation suggests that local
NO concentration may have changed slightly over the 10 month period, but remained lower
than the initial rise observed at the time of implantation, possibly caused by tissue damage
involved in the surgical procedure. Consistent with this interpretation, inflammation was not
observed in tissue surrounding the sites of gel implantation at the conclusion of the long-
term studies (Fig. 5e). A particularly compelling aspect of these findings is that a change in
SWNT concentration within the alginate gels or an alteration in gel composition
(Supplemental Fig. S5) changes the timescale and degree of signal quenching. Hence, a
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sensor library can be constructed to contain gels with different NO concentration limits,
allowing for specification directly related to the disease or condition of interest.
Conclusions
In conclusion, we have shown a reversible, direct optical sensor for in vivo NO detection
with a detection limit of about 1 μM made with semiconducting SWNT, thus demonstrating
that such sensors hold high potential for in vivo chemical detection. Due to the absence of
photobleaching, SWNT are virtually stable for years (we report activity for 400 days
observing negligible change of activity). We have demonstrated two modes of operation for
functionalized SWNT sensors: injection followed by localization within the liver and direct
implantation within a specific tissue. We envision that the latter mode could be used to
directly study tissue inflammation, cancer activity and cell signalling39,40.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Characterization and 2Dλ imaging analysis of DNA wrapped SWNT complexes
a, chemical composition of complex with d(AAAT)7 and wrapped (AAAT)7-SWNT and
PEG-(AAAT)7-SWNT. b,c Quenching activity of (AAAT)7-SWNT (red) and PEG-
(AAAT)7-SWNT (blue) sensors quantified by percent quenching of original fluorescence
using a 785 nm photodiode following exposure to (b) RNS and ROS compounds (analyzed
continuously for 10 minutes and once at the 12 hours post addition time point) with error
bars representing standard error (c) NO (analyzed continuously for 30 minutes). (n = 3) d,
2Dλ imaging analysis for (AAAT)7-SWNT in an excised mouse liver 30 minutes after a tail
vein injection of PEG-(AAAT)7-SWNT imaged with white light excitation and an emission
spectrum from 950 to 1050 nm with a 10 nm step and 20 second accumulation time (scale
bars 4 mm).
Iverson et al. Page 11













Figure 2. Effect of PEGylation for tail vein injected SWNT
a, (AAAT)7-SWNT remains within the tail following injection (50 mg L−1) into left then
right tail veins, cross-sectional view of tail shows that the (AAAT)7-SWNT is localized
within the veins. b, Gel electrophoresis data showing the difference in electrophoretic
mobility of (AAAT)7-SWNT (red) when mixed with FBS as opposed to PEG-(AAAT)7-
SWNT (blue) which was not altered by the addition of FBS. c, Mouse tail following
injection (50 mg L−1) of PEG-(AAAT)7-SWNT into the left tail vein, cross-sectional view
shows clearance of SWNT from the vessel. (n = 3, scale bars 2 mm)
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Figure 3. Biodistribution and biocompatibility of PEG-(AAAT)7-SWNT in 129 mice
Data from mice sacrificed at various time points following tail vein injection of PEG-
(AAAT)7-SWNT (200 μL injection of 50 mg L−1 SWNT) a, Histology images (H&E
stained, 60× magnification, scale bar 10 μm) of liver tissue sections for control mouse and
mouse received PEG-(AAAT)7-SWNT 30 minutes before sacrifice revealing
biocompatibility of SWNT due to lack of inflammatory cell recruitment. b, A representation
of SWNT presence (+) or absence (−) in blood, tail (site of injection), lung, liver, kidney and
urine following sacrifice and excision (as determined by Raman spectroscopy on fresh
samples). c, representative Raman spectrum of those used to determine SWNT localization
in (b). d, Images of excised livers deconvoluted with 2Dλ technology showing first PEG-
(AAAT)7-SWNT localization relative in the liver then a heatmap of fluorescence (scale bar
4 mm). e, Chart with quantification of SWNT fluorescence in mouse livers excised at
various time points following tail vein injection of 200 μL of 50 mg L−1 PEG-(AAAT)7-
SWNT. (n = 3–5 mice per time point, error bars are s.e.m.) f, Graph of SWNT fluorescence
distribution in mouse livers shown in e, shows similar peak values (10.5, 11.2, 8.1, 9.6 and
10.4) and standard deviations (73.19, 56.43, 63.07, 48.92 and 49.51 a.u.) for all time points.
g, Mathematical model of PEG-(AAAT)7-SWNT concentration in mouse liver over time
(same livers as those shown in e).
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Figure 4. In vivo sensor quenching due to inflammation
a, Inflamed (RcsX treated) and control (healthy) mice imaged in situ 30 minutes after tail
vein injection of PEG-(AAAT)7-SWNT (200 μL injection of 50 mg L−1 SWNT) with their
livers exposed then the excised liver imaged immediately following sacrifice, displaying the
SWNT quenching that is observed in the inflamed animal (scale bars 4 mm). b, Chart
showing quantification of SWNT fluorescence, including an extra control of a RcsX treated
(inflamed) mouse that received a tail vein injection of saline. (n = 10, error bars are s.e.m.) c,
Graph of SWNT fluorescence distribution in mouse livers shown in a and b.
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Figure 5. Additional sensor construct with broader in vivo localization possibilities and long term
sensing capabilities
a,b Quenching activity of (AAAT)7-SWNT (red) and Alginate-(AAAT)7-SWNT (green)
sensors quantified by percent quenching of original fluorescence using a 785 nm photodiode
following exposure to (a) RNS and ROS compounds (analyzed continuously for 10 minutes
and once at the 12 hours post addition time point) with error bars representing standard error
(b) NO (analyzed continuously for 30 minutes for (AAAT)7-SWNT and just under 45 hours
for Alginate-(AAAT)7-SWNT) (dashed vertical line represents a change in the timescale
from minutes to hours). (n = 3) c, Image of mouse following implantation of two Alginate-
(AAAT)7-SWNT gels on day 0 (immediately after implantation of gel 2) and on day 4 after
the fluorescence has returned. (scale bar 4 mm) d, Images of Alginate-(AAAT)7-SWNT gel
prior to subcutaneous implantation and at various time points throughout the 300 day test
period (scale bar 4mm) and (e) quantification of peak SWNT fluorescence for one of the
mice tested displaying long term consistency of SWNT signal. f, Histology images (H&E
stained, 10x (day 4 and day 400) and 20x (day 180), scale bars 10 μm) from mice sacrificed
at three different time points following the subcutaneous implantation of Alginate-
(AAAT)7-SWNT show very little to no inflammation.
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